{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:03:14Z","timestamp":1791928994489,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T00:00:00Z","timestamp":1695945600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019779","name":"Qatar National Library","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019779","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.ajo.2023.09.022","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T03:24:19Z","timestamp":1696389859000},"page":"218-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Tropicamide Versus Cyclopentolate for Cycloplegic Refraction in Pediatric Patients With Brown Irides: A Randomized Clinical Trial"],"prefix":"10.1016","volume":"257","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2365-5731","authenticated-orcid":false,"given":"Wejdan","family":"Al-Thawabieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7601-1211","authenticated-orcid":false,"given":"Rami","family":"Al-Omari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diala Walid","family":"Abu-Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2703-0942","authenticated-orcid":false,"given":"Mohammad T.","family":"Abuawwad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2617-5086","authenticated-orcid":false,"given":"Abdullah","family":"Al-awadhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2953-2188","authenticated-orcid":false,"given":"Hashem","family":"Abu Serhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ajo.2023.09.022_bib0001","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/aos.12642","article-title":"Cycloplegic refraction is the gold standard for epidemiological studies","volume":"93","author":"Morgan","year":"2015","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2023.09.022_bib0002","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00006324-200401000-00010","article-title":"Accuracy of noncycloplegic autorefraction in school-age children in China","volume":"81","author":"Zhao","year":"2004","journal-title":"Optom Vis Sci"},{"issue":"2","key":"10.1016\/j.ajo.2023.09.022_bib0003","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ajo.2007.03.041","article-title":"Necessity of cycloplegia for assessing refractive error in 12-year-old children: a population-based study","volume":"144","author":"Fotedar","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2023.09.022_bib0004","doi-asserted-by":"crossref","first-page":"e633","DOI":"10.1111\/aos.13569","article-title":"Comparison of noncycloplegic and cycloplegic autorefraction in categorizing refractive error data in children","volume":"95","author":"Sankaridurg","year":"2017","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2023.09.022_bib0005","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1755-3768.1991.tb04825.x","article-title":"Automated refraction. A comparative study of automated refraction with the Nidek AR-1000 autorefractor and retinoscopy","volume":"69","author":"Salvesen","year":"1991","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"6","key":"10.1016\/j.ajo.2023.09.022_bib0006","first-page":"162","article-title":"Automatic refractometry, reliability of the determination of type and degree of refraction anomalies. Automatska refraktometrija, pouzdanost odredivanja vrste i visine refrakcijske anomalije","volume":"120","author":"Kovaci\u0107","year":"1998","journal-title":"Lijec Vjesn"},{"issue":"8","key":"10.1016\/j.ajo.2023.09.022_bib0007","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/00006324-199308000-00013","article-title":"1% cyclopentolate hydrochloride: another look at the time course of cycloplegia using an objective measure of the accommodative response","volume":"70","author":"Manny","year":"1993","journal-title":"Optom Vis Sci"},{"issue":"3","key":"10.1016\/j.ajo.2023.09.022_bib0008","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/09273972.2019.1629466","article-title":"A randomized clinical trial using atropine, cyclopentolate, and tropicamide to compare refractive outcome in hypermetropic children with a dark iris; skin pigmentation and crying as significant factors for hypermetropic outcome","volume":"27","author":"van Minderhout","year":"2019","journal-title":"Strabismus"},{"issue":"4","key":"10.1016\/j.ajo.2023.09.022_bib0009","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/aos.15016","article-title":"Eye colour and skin pigmentation as significant factors for refractive outcome and residual accommodation in hypermetropic children: a randomized clinical trial using cyclopentolate 1% and tropicamide 1%","volume":"100","author":"van Minderhout","year":"2022","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ajo.2023.09.022_bib0010","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/OPTO.S217645","article-title":"Cycloplegia in children: an optometrist's perspective","volume":"12","author":"Major","year":"2020","journal-title":"Clin Optom (Auckl)"},{"issue":"3","key":"10.1016\/j.ajo.2023.09.022_bib0011","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4103\/0300-1652.184065","article-title":"Cycloplegic effect of atropine compared with cyclopentolate-tropicamide combination in children with hypermetropia","volume":"57","author":"Sani","year":"2016","journal-title":"Niger Med J"},{"issue":"9","key":"10.1016\/j.ajo.2023.09.022_bib0012","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jfo.2014.05.005","article-title":"Objective refraction in black children: cyclopentolate and tropicamide combination, a reliable alternative to atropine? R\u00e9fraction objective chez l'enfant m\u00e9lanoderme: l'association cyclopentolate et tropicamide, une alternative fiable \u00e0 l'atropine?","volume":"37","author":"Ka","year":"2014","journal-title":"J Fr Ophtalmol"},{"issue":"1","key":"10.1016\/j.ajo.2023.09.022_bib0013","doi-asserted-by":"crossref","first-page":"88","DOI":"10.4103\/0028-3886.39324","article-title":"Acute progressive midbrain hemorrhage after topical ocular cyclopentolate administration","volume":"56","author":"Calisaneller","year":"2008","journal-title":"Neurol India"},{"issue":"10","key":"10.1016\/j.ajo.2023.09.022_bib0014","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/eye.2012.149","article-title":"Systemic toxicity of topical cyclopentolate eyedrops in a child","volume":"26","author":"Pooniya","year":"2012","journal-title":"Eye (Lond)"},{"issue":"3","key":"10.1016\/j.ajo.2023.09.022_bib0015","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0377-1237(10)80069-3","article-title":"Neurotoxic effects of topical cyclopentolate","volume":"66","author":"Rajeev","year":"2010","journal-title":"Med J Armed Forces India"},{"key":"10.1016\/j.ajo.2023.09.022_bib0016","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.2147\/OPTH.S388982","article-title":"Ocular cyclopentolate: a mini review concerning its benefits and risks","volume":"16","author":"Contreras-Salinas","year":"2022","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2023.09.022_bib0017","doi-asserted-by":"crossref","first-page":"915","DOI":"10.24953\/turkjped.2022.125","article-title":"Cyclopentolate eye drops-induced anaphylaxis in an infant","volume":"64","author":"Terece","year":"2022","journal-title":"Turk J Pediatr"},{"key":"10.1016\/j.ajo.2023.09.022_bib0018","first-page":"897","article-title":"Time of maximum cycloplegia after instillation of cyclopentolate 1% in children with brown irises","volume":"10","author":"Laojaroenwanit","year":"2016","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2023.09.022_bib0019","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/09273972.2021.2022716","article-title":"Time for effective cycloplegia in patients with brown iris","volume":"30","author":"Al-Omari","year":"2022","journal-title":"Strabismus"},{"issue":"3","key":"10.1016\/j.ajo.2023.09.022_bib0020","doi-asserted-by":"crossref","first-page":"923","DOI":"10.4314\/ahs.v17i3.36","article-title":"Owusu-Ansah A. Onset and duration of cycloplegic action of 1% cyclopentolate - 1% tropicamide combination","volume":"17","author":"Kyei","year":"2017","journal-title":"Afr Health Sci"},{"issue":"2","key":"10.1016\/j.ajo.2023.09.022_bib0021","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1089\/jop.1994.10.431","article-title":"Systemic absorption and anticholinergic activity of topically applied tropicamide","volume":"10","author":"Vuori","year":"1994","journal-title":"J Ocul Pharmacol"},{"issue":"3","key":"10.1016\/j.ajo.2023.09.022_bib0022","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.optom.2017.09.001","article-title":"Comparison of cyclopentolate versus tropicamide cycloplegia: a systematic review and meta-analysis","volume":"11","author":"Yazdani","year":"2018","journal-title":"J Optom"},{"issue":"1","key":"10.1016\/j.ajo.2023.09.022_bib0023","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s12886-021-02001-6","article-title":"A randomized clinical trial using cyclopentolate and tropicamide to compare cycloplegic refraction in Chinese young adults with dark irises","volume":"21","author":"Pei","year":"2021","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2023.09.022_bib0024","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jcrs.2004.10.068","article-title":"Comparison of tropicamide and cyclopentolate for cycloplegic refractions in myopic adult refractive surgery patients","volume":"31","author":"Hofmeister","year":"2005","journal-title":"J Cataract Refract Surg"},{"issue":"4","key":"10.1016\/j.ajo.2023.09.022_bib0025","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1089\/jop.1998.14.331","article-title":"The cycloplegic effects of cyclopentolate and tropicamide on myopic children","volume":"14","author":"Lin","year":"1998","journal-title":"J Ocul Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.ajo.2023.09.022_bib0026","first-page":"1728","article-title":"Tropicamide (1%): an effective cycloplegic agent for myopic children","volume":"42","author":"Manny","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.ajo.2023.09.022_bib0027","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/00006324-199312000-00005","article-title":"Comparison of cyclopentolate versus tropicamide cycloplegia in children","volume":"70","author":"Egashira","year":"1993","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.ajo.2023.09.022_bib0028","first-page":"635","article-title":"Comparison of cycloplegic retinoscopy using cyclopentolate or tropicamide eye drops in an epidemiologic study of pediatric refraction among 1907 school-aged children","volume":"6","author":"Pi","year":"2011","journal-title":"Scient Res Essay"},{"issue":"1","key":"10.1016\/j.ajo.2023.09.022_bib0029","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1741-7015-8-18","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials","volume":"8","author":"Schulz","year":"2010","journal-title":"BMC Med"},{"issue":"8","key":"10.1016\/j.ajo.2023.09.022_bib0030","first-page":"1592","article-title":"Evaluation of an iris color classification system. The Eye Disorders Case-Control Study Group","volume":"31","author":"Seddon","year":"1990","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"105","key":"10.1016\/j.ajo.2023.09.022_bib0031","first-page":"5","article-title":"High myopia and its risks","volume":"32","author":"Williams","year":"2019","journal-title":"Community Eye Health"},{"key":"10.1016\/j.ajo.2023.09.022_bib0032","series-title":"Optometric Clinical Practice Guideline: Care of the Patient With Hyperopia. Vols. 1-29","author":"Moore","year":"1997"},{"issue":"1","key":"10.1016\/j.ajo.2023.09.022_bib0033","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/cxo.12375","article-title":"A comparison of cycloplegic autorefraction and retinoscopy in Indian children","volume":"100","author":"Guha","year":"2017","journal-title":"Clin Exp Optom"},{"key":"10.1016\/j.ajo.2023.09.022_bib0034","first-page":"1655","article-title":"Wait time as a driver of overall patient satisfaction in an ophthalmology clinic","volume":"7","author":"McMullen","year":"2013","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2023.09.022_bib0035","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/j.1442-9071.2004.00863.x","article-title":"Comparative study on the safety and efficacy of different cycloplegic agents in children with darkly pigmented irides","volume":"32","author":"Fan","year":"2004","journal-title":"Clin Exp Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2023.09.022_bib0036","first-page":"43","article-title":"bis-Tropamide, a new parasympatholytic","author":"Merrill","year":"1960","journal-title":"Curr Ther Res"},{"issue":"5","key":"10.1016\/j.ajo.2023.09.022_bib0037","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00006324-198105000-00003","article-title":"Dose-response effects of tropicamide HCl","volume":"58","author":"Pollack","year":"1981","journal-title":"Am J Optom Physiol Opt"},{"key":"10.1016\/j.ajo.2023.09.022_bib0038","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/archopht.1961.01840020634005","article-title":"Tropicamide, a new cycloplegic mydriatic","volume":"65","author":"Gettes","year":"1961","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2023.09.022_bib0039","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/00006324-198610000-00001","article-title":"Pharmacokinetics of topically applied cyclopentolate HCl and tropicamide","volume":"63","author":"Lovasik","year":"1986","journal-title":"Am J Optom Physiol Opt"},{"issue":"2","key":"10.1016\/j.ajo.2023.09.022_bib0040","first-page":"113","article-title":"Diagnostic pharmaceutical agents: side effects encountered in a study of 15,000 applications","volume":"51","author":"Yolton","year":"1980","journal-title":"J Am Optom Assoc"},{"issue":"6","key":"10.1016\/j.ajo.2023.09.022_bib0041","doi-asserted-by":"crossref","first-page":"e458","DOI":"10.1111\/aos.12388","article-title":"What is the appropriate age cut-off for cycloplegia in refraction?","volume":"92","author":"Sanfilippo","year":"2014","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2023.09.022_bib0042","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3126\/nepjoph.v3i2.5267","article-title":"Accommodation: its relation to refractive errors, amblyopia and biometric parameters","volume":"3","author":"Maheshwari","year":"2011","journal-title":"Nepal J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2023.09.022_bib0043","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1006\/jhev.2000.0403","article-title":"The evolution of human skin coloration","volume":"39","author":"Jablonski","year":"2000","journal-title":"J Hum Evol"},{"issue":"4","key":"10.1016\/j.ajo.2023.09.022_bib0044","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00006324-200104000-00010","article-title":"Retinoscopy in infants using a near noncycloplegic technique, cycloplegia with tropicamide 1%, and cycloplegia with cyclopentolate 1%","volume":"78","author":"Twelker","year":"2001","journal-title":"Optom Vis Sci"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939423004038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939423004038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:55:57Z","timestamp":1757598957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939423004038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":44,"alternative-id":["S0002939423004038"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2023.09.022","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tropicamide Versus Cyclopentolate for Cycloplegic Refraction in Pediatric Patients With Brown Irides: A Randomized Clinical Trial","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2023.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}